Related Experiment Videos
5-Hydroxytryptamine potentiates vasoconstrictor effect of endothelin-1
B C Yang1, W W Nichols, D L Lawson
1Department of Medicine, University of Florida College of Medicine, Gainesville 32610.
The American Journal of Physiology
|April 1, 1992
Summary
5-hydroxytryptamine (5-HT) potentiates endothelin-1 (ET-1) induced contractions in rat aortic rings, an effect blocked by antagonists and involving thromboxane A2 and calcium channels. This highlights 5-HT
Area of Science:
- Pharmacology
- Cardiovascular Physiology
Background:
- 5-hydroxytryptamine (5-HT) and endothelin-1 (ET-1) are key vasoactive substances.
- Understanding their interactions is crucial for cardiovascular research.
Purpose of the Study:
- To investigate the interaction between 5-HT and ET-1 on rat aortic ring contraction.
- To elucidate the mechanisms underlying 5-HT potentiation of ET-1 effects.
Main Methods:
- Rat aortic rings were pretreated with 5-HT or ET-1.
- Contractile responses were measured.
- The effects of receptor antagonists (LY 53857, SQ 29548) and calcium channel blockers (verapamil, diltiazem) were assessed.
Main Results:
- 5-HT pretreatment potentiated ET-1-induced contraction, but not vice versa.
- The 5-HT receptor antagonist LY 53857 blocked this synergistic effect.
- Indomethacin, SQ 29548, verapamil, and diltiazem attenuated the synergistic contractions, suggesting roles for thromboxane A2 and calcium channels.
Conclusions:
- 5-HT potentiates ET-1-mediated vasoconstriction in rat aorta.
- This potentiation involves 5-HT receptors, thromboxane A2 pathways, and voltage-dependent calcium channels.
- The findings provide insights into the complex regulation of vascular tone.